Ipamorelin

Overview

Ipamorelin is a synthetic pentapeptide that functions as a selective growth hormone secretagogue (GHS). It is investigated exclusively in controlled preclinical and in vitro research settings for its potential role in growth hormone–related cellular signaling pathways and metabolic regulation. Research focuses on how Ipamorelin interacts with the ghrelin receptor (GHS-R1a) to influence intracellular pathways associated with pituitary signaling and bioenergetic modulation in non-human experimental models.

Specifications

• Unit Size: 10 mg per vial

• Form: Lyophilized powder

• Storage: Store dry at 2 °C–8 °C. After reconstitution, refrigerate at 2 °C–8 °C and use within 10–14 days.

• Documentation: Certificate of Analysis (COA) and Material Safety Data Sheet (MSDS) available upon request.

Research Context

Preclinical and in vitro studies have explored Ipamorelin in relation to:

• Growth hormone secretagogue receptor (GHS-R1a) activation and intracellular signaling pathways

• Pituitary cell stimulation and GH/IGF-1 axis models

• Mechanistic comparison with other peptide secretagogues under laboratory conditions

• Cellular and metabolic responses within endocrine research frameworks

All data derive from non-clinical and laboratory studies. Findings do not imply safety or efficacy in humans or animals.

Intended Use / Restrictions

• For laboratory research use only

• Not for human or veterinary use

• Not a drug, dietary supplement, or medical device

• Buyer must be a qualified researcher or institution and assumes full responsibility for lawful handling, usage, and compliance with applicable research regulations.

Important Notice

The information provided is intended solely for scientific and educational purposes. The seller makes no representations or claims regarding the safety, effectiveness, or suitability of this material for any clinical application. All handling, storage, and disposal must follow appropriate institutional biosafety protocols.